Bogart Wealth’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.2K Buy
251
+200
+392% +$20.5K ﹤0.01% 745
2026
Q2
$5.02K Hold
51
– – ﹤0.01% 1201
2026
Q1
$4.38K Buy
51
+1
+2% +$88 ﹤0.01% 1098
2025
Q4
$4.27K Buy
+50
New +$3.99K ﹤0.01% 1037
2018
Q1
– Sell
-63
Closed -$3K – 357
2017
Q4
$3K Sell
63
-78
-55% -$4.01K ﹤0.01% 294
2017
Q3
$7K Buy
+141
New +$7.24K 0.01% 258
2017
Q1
– Sell
-263,424
Closed -$12.4M – 65
2016
Q4
$12.4M Buy
+263,424
New +$12.5M 8.41% 4

Other funds holding IHE

Bogart Wealth's IHE Position: Q3 2026 in Review

Bogart Wealth increased its iShares US Pharmaceuticals ETF (IHE) stake by 392% in Q3 2026, buying an estimated $20.5K and bringing the position to 251 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #745.

Bogart Wealth first reported a position in IHE in Q4 2016 and has held it in 7 quarters since. The position peaked at $12.4M in Q4 2016. 245 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Bogart Wealth held 251 shares of iShares US Pharmaceuticals ETF worth $25.2K as of Q3 2026.
  • Bogart Wealth bought 200 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $20.5K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #745 holding.
  • Bogart Wealth first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and has held it in 7 quarters since.
  • Bogart Wealth's iShares US Pharmaceuticals ETF position peaked at $12.4M in Q4 2016.
  • 245 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.